Related Experiment Videos
[Diffuse interstitial pulmonary fibrosis and bronchial cancer]
N Rouetbi1, M Battikh, A el Kamel
1Service de Pneumologie, Hôpital Universitaire Fattouma Bourguiba de Monastir, Tunisie.
Revue De Pneumologie Clinique
|February 24, 2000
Summary
Patients with diffuse interstitial pulmonary fibrosis had a 25% lung cancer mortality rate. Smoking significantly increased lung cancer risk in these patients, with squamous cell carcinoma being the predominant type.
Area of Science:
- Pulmonology
- Oncology
Background:
- Diffuse interstitial pulmonary fibrosis (DIPF) is a chronic lung disease.
- Lung cancer is a significant cause of mortality.
- The relationship between DIPF and lung cancer requires further investigation.
Purpose of the Study:
- To investigate the incidence and characteristics of lung cancer in patients with DIPF.
- To compare lung cancer in patients with and without DIPF.
Main Methods:
- Retrospective study of 28 patients with DIPF.
- Analysis of chest x-rays for lung cancer indicators.
- Comparison of 7 lung cancer cases with DIPF to 174 cases without DIPF.
Main Results:
- Mortality due to lung cancer was 25% (7/28) in patients with DIPF.
- 5 of 7 cases showed suspicious chest x-ray findings.
- All 7 cases were squamous cell carcinoma.
- Higher smoking prevalence in DIPF patients who developed lung cancer (p=0.016).
- Lung cancer in DIPF cases showed higher peripheral and lower lobe involvement.
Conclusions:
- DIPF is associated with a significant risk of lung cancer, primarily squamous cell carcinoma.
- Smoking is a key risk factor for lung cancer in patients with DIPF.
- Lung cancer in DIPF patients may present with distinct radiological features.